Michael Zile to Natriuretic Peptides
This is a "connection" page, showing publications Michael Zile has written about Natriuretic Peptides.
Connection Strength
1.173
-
Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction. J Cardiovasc Transl Res. 2013 Aug; 6(4):501-15.
Score: 0.436
-
Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials. Am Heart J. 2021 07; 237:45-53.
Score: 0.186
-
Should We Test for Diastolic Dysfunction? How and How Often? JACC Cardiovasc Imaging. 2020 01; 13(1 Pt 2):297-309.
Score: 0.166
-
Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of?Heart Failure. JACC Heart Fail. 2018 07; 6(7):564-569.
Score: 0.152
-
Natriuretic Peptides, 6-Min Walk Test, and?Quality-of-Life Questionnaires as Clinically Meaningful Endpoints in HF Trials. J Am Coll Cardiol. 2016 Dec 20; 68(24):2690-2707.
Score: 0.140
-
Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HF. Eur J Heart Fail. 2022 04; 24(4):672-677.
Score: 0.050
-
Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart?Failure Position Paper. JACC Heart Fail. 2020 05; 8(5):347-358.
Score: 0.044